These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26573914)

  • 21. Novel osteoclast signaling mechanisms.
    Shinohara M; Takayanagi H
    Curr Osteoporos Rep; 2007 Jun; 5(2):67-72. PubMed ID: 17521508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of Siglec-15 in regulating RAP1/RAC signaling in cytoskeletal remodeling in osteoclasts mediated by macrophage colony-stimulating factor.
    Kobayashi H; Terkawi MA; Ota M; Hasegawa T; Yamamoto T; Shimizu T; Sato D; Fujita R; Murakami T; Amizuka N; Iwasaki N; Takahata M
    Bone Res; 2024 Jun; 12(1):35. PubMed ID: 38849345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency.
    Wu Y; Torchia J; Yao W; Lane NE; Lanier LL; Nakamura MC; Humphrey MB
    PLoS One; 2007 Jul; 2(7):e586. PubMed ID: 17611621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints.
    Crotti TN; Dharmapatni AA; Alias E; Zannettino AC; Smith MD; Haynes DR
    Arthritis Res Ther; 2012 Nov; 14(6):R245. PubMed ID: 23146195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RANKing intracellular signaling in osteoclasts.
    Feng X
    IUBMB Life; 2005 Jun; 57(6):389-95. PubMed ID: 16012047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSTA plays a role in osteoclast formation and bone resorption by mediating the DAP12/TREM2 pathway.
    Wei R; Zhang L; Hu W; Wu J; Zhang W
    Biochem Biophys Res Commun; 2022 Oct; 627():12-20. PubMed ID: 36007331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis.
    Shimizu T; Takahata M; Kameda Y; Endo T; Hamano H; Hiratsuka S; Ota M; Iwasaki N
    Bone; 2015 Oct; 79():65-70. PubMed ID: 26027508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ly49Q, an ITIM-bearing NK receptor, positively regulates osteoclast differentiation.
    Hayashi M; Nakashima T; Kodama T; Makrigiannis AP; Toyama-Sorimachi N; Takayanagi H
    Biochem Biophys Res Commun; 2010 Mar; 393(3):432-8. PubMed ID: 20153723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.
    Faccio R; Zou W; Colaianni G; Teitelbaum SL; Ross FP
    J Cell Biochem; 2003 Dec; 90(5):871-83. PubMed ID: 14624447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Finely-Tuned Calcium Oscillations in Osteoclast Differentiation and Bone Resorption.
    Okada H; Okabe K; Tanaka S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone.
    Humphrey MB; Lanier LL; Nakamura MC
    Immunol Rev; 2005 Dec; 208():50-65. PubMed ID: 16313340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
    PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyethylene particles stimulate expression of ITAM-related molecules in peri-implant tissues and when stimulating osteoclastogenesis in vitro.
    Alias E; Dharmapatni AS; Holding AC; Atkins GJ; Findlay DM; Howie DW; Crotti TN; Haynes DR
    Acta Biomater; 2012 Aug; 8(8):3104-12. PubMed ID: 22554886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The enigmatic function of TREM-2 in osteoclastogenesis.
    Colonna M; Turnbull I; Klesney-Tait J
    Adv Exp Med Biol; 2007; 602():97-105. PubMed ID: 17966394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Regulation of osteoclast development by immunoglobulin-like receptors].
    Takai T; Inui M; Inoue K; Mori Y
    Nihon Rinsho; 2005 Sep; 63(9):1562-8. PubMed ID: 16164212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
    Sordillo EM; Pearse RN
    Cancer; 2003 Feb; 97(3 Suppl):802-12. PubMed ID: 12548579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor activator of NF-κB ligand-dependent expression of caveolin-1 in osteoclast precursors, and high dependency of osteoclastogenesis on exogenous lipoprotein.
    Hada N; Okayasu M; Ito J; Nakayachi M; Hayashida C; Kaneda T; Uchida N; Muramatsu T; Koike C; Masuhara M; Sato T; Hakeda Y
    Bone; 2012 Jan; 50(1):226-36. PubMed ID: 22075210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.
    Sabokbar A; Mahoney DJ; Hemingway F; Athanasou NA
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):16-26. PubMed ID: 26578261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line.
    Anfossi N; Lucas M; Diefenbach A; Bühring HJ; Raulet D; Tomasello E; Vivier E
    Eur J Immunol; 2003 Dec; 33(12):3514-22. PubMed ID: 14635062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RANKL-RANK signaling in osteoclastogenesis and bone disease.
    Wada T; Nakashima T; Hiroshi N; Penninger JM
    Trends Mol Med; 2006 Jan; 12(1):17-25. PubMed ID: 16356770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.